Annette Logan-Parker: A Hemophilia B Breakthrough – From Weekly Infusions to One Treatment
Annette Logan-Parker, Founder and Chief Advocacy and Innovation Officer at Cure 4 The Kids Foundation, Innovation Council Member at Coalition Against Childhood Cancer (CAC2), shared on LinkedIn:
”He flew from Arizona to Las Vegas for a single infusion…and never needed another one.
For 39 years, this patient lived with hemophilia B.
That meant intravenous infusions of clotting factor every week, sometimes multiple times a week, just to prevent a bleed that could put him in the hospital.
Every week. For nearly four decades. That was his life.
In 2024, he came to our clinic and received Hemgenix (an FDA-approved gene therapy that delivers a working copy of the gene his body was missing).
One infusion. One afternoon.
More than a year later, his body is producing its own clotting factor. No more weekly treatments. No more planning his entire life around his next infusion.
Cure 4 The Kids Foundation was the first center in Nevada to administer this therapy, and one of only a handful on the entire West Coast.
This is what research looks like when it reaches the bedside. And it’s why Research Recognition Week matters.
Read the full story on our blog, including what families need to know about gene therapy, who’s eligible, and what’s coming next.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 13:25Wolfgang Miesbach: Platelet Variation and How Do They Move Over Time?
-
Apr 15, 2026, 12:44Marwa Elnahas: 4Ts Scoring Tool for Heparin – Induced Thrombocytopenia
-
Apr 15, 2026, 12:27Laurent Bertoletti: Joining Global Experts to Improve Thrombosis Care in Cancer for the ICTHIC 16th Edition
-
Apr 15, 2026, 12:13Francesco Antonio Veneziano: JCDD MDPI Calls for Papers on Advances in Thrombosis and Antithrombotic Therapy
-
Apr 15, 2026, 11:05Julius Kyei Baffour: Understanding Thrombophilia Testing and Patient Risk
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care